Pages that link to "Q69793546"

The following pages link to Estimation of area under the curve for drugs subject to enterohepatic cycling (Q69793546):

Displaying 20 items.

• An open study of tolerability and pharmacokinetics of raclopride extended release capsules in psychiatric patients: a Canadian study (Q33921598) (← links)
• Enterohepatic circulation: physiological, pharmacokinetic and clinical implications (Q34774063) (← links)
• Combining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone (Q37227488) (← links)
• Preclinical pharmacology of the antitumor agent O-6-methylguanine in CDF1 mice (Q41584807) (← links)
• Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism. (Q42149212) (← links)
• A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibe (Q43664070) (← links)
• Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations (Q44340761) (← links)
• A recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference (Q44564695) (← links)
• Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer. (Q44872854) (← links)
• An experimental design strategy for quantitating complex pharmacokinetic models: enterohepatic circulation with time-varying gallbladder emptying as an example (Q45063944) (← links)
• Mycophenolic Acid and Its Metabolites in Kidney Transplant Recipients: A Semimechanistic Enterohepatic Circulation Model to Improve Estimating Exposure. (Q48252498) (← links)
• Asymptotics and bioavailability in multicompartment pharmacokinetic models with enterohepatic circulation. (Q52014814) (← links)
• Local identifiability for two and three-compartment pharmacokinetic models with time-lags. (Q52236713) (← links)
• Pharmacokinetics of raclopride formulations. Influence of prolactin and tolerability in healthy male volunteers (Q68078779) (← links)
• Single-dose and steady-state kinetics of morphine and its metabolites in cancer patients--a comparison of two oral formulations (Q68252140) (← links)
• Mean residence time for drugs subject to enterohepatic cycling (Q69789079) (← links)
• Effect modelling for drugs undergoing enterohepatic circulation (Q72035850) (← links)
• Minimal biliary excretion and enterohepatic recirculation of metoclopramide in patients with extrahepatic cholestasis (Q72252544) (← links)
• Absorption and disposition including enterohepatic circulation of (14C) roquinimex after oral administration to healthy volunteers (Q73254597) (← links)
• Enterohepatic circulation of glucuronide metabolites of drugs in dog (Q92108267) (← links)